LIVERPOOL, ENGLAND – The risk of atypical femoral fractures with long-term bisphosphonate treatment may be relatively low overall, but clinicians need to be aware, experts said at the recent British...

Field of Interest: Endocrinology

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.